Catalyst
Slingshot members are tracking this event:
FDA Approval of Docetaxel Injection, First and Only Alcohol-Free Formulation Approved in U.S.
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| EGRX |
|
|
||||
Slingshot Insights Explained
Catalyst Date
Occurred on:
Dec 24, 2015
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Docetaxel, Fda, Aproval, Breast Cancer, Non-small Cell Lung Cancer, Prostate Cancer, Gastric Adenocarcinoma, Head And Neck Cancer
